{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:32:58Z","timestamp":1787164378875,"version":"build-2736575974"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM084979"],"award-info":[{"award-number":["R01GM084979"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG061447"],"award-info":[{"award-number":["R01AG061447"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10571-020-00936-w","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T07:02:58Z","timestamp":1598252578000},"page":"1613-1624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Liang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-8378","authenticated-orcid":false,"given":"Huafeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"issue":"2","key":"936_CR1","first-page":"1183","volume":"55","author":"N Abu-Omar","year":"2018","unstructured":"Abu-Omar N, Das J, Szeto V, Feng ZP (2018) Neuronal ryanodine receptors in development and aging. MolNeurobiol 55(2):1183\u20131192","journal-title":"MolNeurobiol"},{"issue":"36","key":"936_CR2","doi-asserted-by":"publisher","first-page":"12093","DOI":"10.1523\/JNEUROSCI.2495-13.2014","volume":"34","author":"D Aggad","year":"2014","unstructured":"Aggad D, Veriepe J, Tauffenberger A, Parker JA (2014) TDP-43 toxicity proceeds via calcium dysregulation and necrosis in aging Caenorhabditis elegans motor neurons. J Neurosci 34(36):12093\u201312103","journal-title":"J Neurosci"},{"key":"936_CR3","doi-asserted-by":"publisher","first-page":"104671","DOI":"10.1016\/j.nbd.2019.104671","volume":"134","author":"D Belvisi","year":"2019","unstructured":"Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G (2019) Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: what do prospective studies suggest? Neurobiol Dis 134:104671","journal-title":"Neurobiol Dis"},{"issue":"1","key":"936_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/35036035","volume":"1","author":"MJ Berridge","year":"2000","unstructured":"Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1(1):11\u201321","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"936_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1085\/jgp.201411255","volume":"144","author":"P Braubach","year":"2014","unstructured":"Braubach P, Orynbayev M, Andronache Z, Hering T, Landwehrmeyer GB, Lindenberg KS, Melzer W (2014) Altered Ca(2+) signaling in skeletal muscle fibers of the R6\/2 mouse, a model of Huntington's disease. J Gen Physiol 144(5):393\u2013413","journal-title":"J Gen Physiol"},{"issue":"5","key":"936_CR6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.neurobiolaging.2011.03.011","volume":"33","author":"AM Bruno","year":"2012","unstructured":"Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE (2012) Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 33(5):1001","journal-title":"Neurobiol Aging"},{"key":"936_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neulet.2018.02.005","volume":"688","author":"DD Bushart","year":"2019","unstructured":"Bushart DD, Shakkottai VG (2019) Ion channel dysfunction in cerebellar ataxia. Neurosci Lett 688:41\u201348","journal-title":"Neurosci Lett"},{"issue":"1","key":"936_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/hmg\/ddu430","volume":"24","author":"M Cassar","year":"2015","unstructured":"Cassar M, Issa AR, Riemensperger T, Petitgas C, Rival T, Coulom H, Iche-Torres M, Han KA, Birman S (2015) A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila. Hum Mol Genet 24(1):197\u2013212","journal-title":"Hum Mol Genet"},{"issue":"12","key":"936_CR9","doi-asserted-by":"publisher","first-page":"e52056","DOI":"10.1371\/journal.pone.0052056","volume":"7","author":"S Chakroborty","year":"2012","unstructured":"Chakroborty S, Briggs C, Miller MB, Goussakov I, Schneider C, Kim J, Wicks J, Richardson JC, Conklin V, Cameransi BG et al (2012) Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease. PLoS ONE 7(12):e52056","journal-title":"PLoS ONE"},{"issue":"24","key":"936_CR11","doi-asserted-by":"publisher","first-page":"18195","DOI":"10.1074\/jbc.M000040200","volume":"275","author":"SL Chan","year":"2000","unstructured":"Chan SL, Mayne M, Holden CP, Geiger JD, Mattson MP (2000) Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J Biol Chem 275(24):18195\u201318200","journal-title":"J Biol Chem"},{"issue":"5","key":"936_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tins.2009.01.006","volume":"32","author":"CS Chan","year":"2009","unstructured":"Chan CS, Gertler TS, Surmeier DJ (2009) Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci 32(5):249\u2013256","journal-title":"Trends Neurosci"},{"issue":"48","key":"936_CR13","doi-asserted-by":"publisher","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","volume":"28","author":"X Chen","year":"2008","unstructured":"Chen X, Tang TS, Tu H, Nelson O, Pook M, Hammer R, Nukina N, Bezprozvanny I (2008) Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J Neurosci 28(48):12713\u201312724","journal-title":"J Neurosci"},{"key":"936_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1750-1326-6-81","volume":"6","author":"X Chen","year":"2011","unstructured":"Chen X, Wu J, Lvovskaya S, Herndon E, Supnet C, Bezprozvanny I (2011) Dantrolene is neuroprotective in Huntington's disease transgenic mouse model. Mol Neurodegener 6:81","journal-title":"Mol Neurodegener"},{"issue":"12","key":"936_CR12","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1016\/j.cellsig.2013.09.004","volume":"25","author":"T Chen","year":"2013","unstructured":"Chen T, Yang YF, Luo P, Liu W, Dai SH, Zheng XR, Fei Z, Jiang XF (2013) Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease. Cell Signal 25(12):2863\u20132870","journal-title":"Cell Signal"},{"issue":"2\u20133","key":"936_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0014-2999(02)01843-5","volume":"447","author":"GV Clodfelter","year":"2002","unstructured":"Clodfelter GV, Porter NM, Landfield PW, Thibault O (2002) Sustained Ca2+-induced Ca2+-release underlies the post-glutamate lethal Ca2+ plateau in older cultured hippocampal neurons. Eur J Pharmacol 447(2\u20133):189\u2013200","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"936_CR16","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s13311-019-00777-6","volume":"16","author":"PA Egorova","year":"2019","unstructured":"Egorova PA, Bezprozvanny IB (2019) Molecular mechanisms and therapeutics for spinocerebellar ataxia type 2. Neurotherapeutics 16(4):1050\u20131073","journal-title":"Neurotherapeutics"},{"issue":"10","key":"936_CR17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1046\/j.0953-816x.2001.01786.x","volume":"14","author":"AV Faure","year":"2001","unstructured":"Faure AV, Grunwald D, Moutin MJ, Hilly M, Mauger JP, Marty I, DeWaard M, Villaz M, Albrieux M (2001) Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex. Eur J Neurosci 14(10):1613\u20131622","journal-title":"Eur J Neurosci"},{"issue":"2\u20133","key":"936_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ceca.2016.02.001","volume":"59","author":"O Forostyak","year":"2016","unstructured":"Forostyak O, Forostyak S, Kortus S, Sykova E, Verkhratsky A, Dayanithi G (2016) Physiology of Ca(2+) signalling in stem cells of different origins and differentiation stages. Cell Calcium 59(2\u20133):57\u201366","journal-title":"Cell Calcium"},{"issue":"6","key":"936_CR19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1091\/mbc.E14-12-1612","volume":"26","author":"KJ Gan","year":"2015","unstructured":"Gan KJ, Silverman MA (2015) Dendritic and axonal mechanisms of Ca2+ elevation impair BDNF transport in Abeta oligomer-treated hippocampal neurons. Mol Biol Cell 26(6):1058\u20131071","journal-title":"Mol Biol Cell"},{"issue":"7","key":"936_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ajh\/hpy046","volume":"31","author":"S Gong","year":"2018","unstructured":"Gong S, Su BB, Tovar H, Mao C, Gonzalez V, Liu Y, Lu Y, Wang KS, Xu C (2018) Polymorphisms within RYR3 gene are associated with risk and age at onset of hypertension, diabetes, and Alzheimer's disease. Am J Hypertens 31(7):818\u2013826","journal-title":"Am J Hypertens"},{"issue":"2","key":"936_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ceca.2009.12.002","volume":"47","author":"J Grosskreutz","year":"2010","unstructured":"Grosskreutz J, Van Den Bosch L, Keller BU (2010) Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47(2):165\u2013174","journal-title":"Cell Calcium"},{"issue":"4","key":"936_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1124\/mol.108.048207","volume":"74","author":"S Guerreiro","year":"2008","unstructured":"Guerreiro S, Toulorge D, Hirsch E, Marien M, Sokoloff P, Michel PP (2008) Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol Pharmacol 74(4):980\u2013989","journal-title":"Mol Pharmacol"},{"key":"936_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2013.11.016","volume":"739","author":"A Guerrero-Hernandez","year":"2014","unstructured":"Guerrero-Hernandez A, Avila G, Rueda A (2014) Ryanodine receptors as leak channels. Eur J Pharmacol 739:26\u201338","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"936_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00001756-199612200-00074","volume":"8","author":"Q Guo","year":"1996","unstructured":"Guo Q, Furukawa K, Sopher BL, Pham DG, Xie J, Robinson N, Martin GM, Mattson MP (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. NeuroReport 8(1):379\u2013383","journal-title":"NeuroReport"},{"issue":"11","key":"936_CR25","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1523\/JNEUROSCI.17-11-04212.1997","volume":"17","author":"Q Guo","year":"1997","unstructured":"Guo Q, Sopher BL, Furukawa K, Pham DG, Robinson N, Martin GM, Mattson MP (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci 17(11):4212\u20134222","journal-title":"J Neurosci"},{"issue":"2\u20133","key":"936_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0014-5793(92)80941-9","volume":"312","author":"Y Hakamata","year":"1992","unstructured":"Hakamata Y, Nakai J, Takeshima H, Imoto K (1992) Primary structure and distribution of a novel ryanodine receptor\/calcium release channel from rabbit brain. FEBS Lett 312(2\u20133):229\u2013235","journal-title":"FEBS Lett"},{"issue":"3","key":"936_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/jvp.12089","volume":"37","author":"JL Haraschak","year":"2014","unstructured":"Haraschak JL, Langston VC, Wang R, Riggs C, Fellman C, Ross MK, Bulla C, Lunsford K, Mackin A, Archer T (2014) Pharmacokinetic evaluation of oral dantrolene in the dog. J Vet Pharmacol Ther 37(3):286\u2013294","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"936_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ceca.2008.03.004","volume":"44","author":"V Hayrapetyan","year":"2008","unstructured":"Hayrapetyan V, Rybalchenko V, Rybalchenko N, Koulen P (2008) The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction. Cell Calcium 44(5):507\u2013518","journal-title":"Cell Calcium"},{"issue":"2","key":"936_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/jnr.20631","volume":"82","author":"K Hernandez-Fonseca","year":"2005","unstructured":"Hernandez-Fonseca K, Massieu L (2005) Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons. J Neurosci Res 82(2):196\u2013205","journal-title":"J Neurosci Res"},{"issue":"3","key":"936_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.neuroscience.2007.09.058","volume":"150","author":"DN Hertle","year":"2007","unstructured":"Hertle DN, Yeckel MF (2007) Distribution of inositol-1,4,5-trisphosphate receptor isotypes and ryanodine receptor isotypes during maturation of the rat hippocampus. Neuroscience 150(3):625\u2013638","journal-title":"Neuroscience"},{"issue":"4","key":"936_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397","journal-title":"Lancet Neurol"},{"issue":"1","key":"936_CR32","first-page":"24","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson's disease MovDisord 28(1):24\u201330","journal-title":"Pathogenesis of Parkinson's disease MovDisord"},{"issue":"6765","key":"936_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/47507","volume":"403","author":"K Hong","year":"2000","unstructured":"Hong K, Nishiyama M, Henley J, Tessier-Lavigne M, Poo M (2000) Calcium signalling in the guidance of nerve growth by netrin-1. Nature 403(6765):93\u201398","journal-title":"Nature"},{"issue":"10","key":"936_CR34","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1177\/0963689717732578","volume":"26","author":"J Hsieh","year":"2017","unstructured":"Hsieh J, Liu JW, Harn HJ, Hsueh KW, Rajamani K, Deng YC, Chia CM, Shyu WC, Lin SZ, Chiou TW (2017) Human olfactory ensheathing cell transplantation improves motor function in a mouse model of type 3 spinocerebellar ataxia. Cell Transplant 26(10):1611\u20131621","journal-title":"Cell Transplant"},{"issue":"6","key":"936_CR35","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1213\/ANE.0b013e3181f7181c","volume":"111","author":"S Inan","year":"2010","unstructured":"Inan S, Wei H (2010) The cytoprotective effects of dantrolene: a ryanodine receptor antagonist. Anesth Analg 111(6):1400\u20131410","journal-title":"Anesth Analg"},{"issue":"4","key":"936_CR36","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.neuroscience.2006.07.034","volume":"142","author":"K Jahn","year":"2006","unstructured":"Jahn K, Grosskreutz J, Haastert K, Ziegler E, Schlesinger F, Grothe C, Dengler R, Bufler J (2006) Temporospatial coupling of networked synaptic activation of AMPA-type glutamate receptor channels and calcium transients in cultured motoneurons. Neuroscience 142(4):1019\u20131029","journal-title":"Neuroscience"},{"key":"936_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fncel.2013.00199","volume":"7","author":"MK Jaiswal","year":"2013","unstructured":"Jaiswal MK (2013) Calcium, mitochondria, and the pathogenesis of ALS: the good, the bad, and the ugly. Front Cell Neurosci 7:199","journal-title":"Front Cell Neurosci"},{"key":"936_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/2052-8426-2-26","volume":"2","author":"MK Jaiswal","year":"2014","unstructured":"Jaiswal MK (2014) Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation. Mol Cell Ther 2:26","journal-title":"Mol Cell Ther"},{"issue":"2","key":"936_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrneurol.2015.249","volume":"12","author":"LV Kalia","year":"2016","unstructured":"Kalia LV, Lang AE (2016) Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol 12(2):65\u201366","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"936_CR40","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/cells8101232","volume":"8","author":"NE Karagas","year":"2019","unstructured":"Karagas NE, Venkatachalam K (2019) Roles for the endoplasmic reticulum in regulation of neuronal calcium homeostasis. Cells 8(10):1232","journal-title":"Cells"},{"issue":"7\u20138","key":"936_CR41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.mad.2010.05.003","volume":"131","author":"H Kawamata","year":"2010","unstructured":"Kawamata H, Manfredi G (2010) Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech Ageing Dev 131(7\u20138):517\u2013526","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"936_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0306-4522(99)00042-1","volume":"92","author":"M Kelliher","year":"1999","unstructured":"Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, Sorrentino V, O'Neill C (1999) Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies. Neuroscience 92(2):499\u2013513","journal-title":"Neuroscience"},{"issue":"1","key":"936_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ceca.2015.11.002","volume":"59","author":"BS Kilpatrick","year":"2016","unstructured":"Kilpatrick BS, Magalhaes J, Beavan MS, McNeill A, Gegg ME, Cleeter MW, Bloor-Young D, Churchill GC, Duchen MR, Schapira AH et al (2016) Endoplasmic reticulum and lysosomal Ca(2)(+) stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts. Cell Calcium 59(1):12\u201320","journal-title":"Cell Calcium"},{"issue":"9","key":"936_CR44","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/00001756-200207020-00012","volume":"13","author":"HJ Kim","year":"2002","unstructured":"Kim HJ, Kim M, Kim SH, Sung JJ, Lee KW (2002) Alteration in intracellular calcium homeostasis reduces motor neuronal viability expressing mutated Cu\/Zn superoxide dismutase through a nitric oxide\/guanylyl cyclase cGMP cascade. NeuroReport 13(9):1131\u20131135","journal-title":"NeuroReport"},{"issue":"4","key":"936_CR45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F (2004) Dantrolene\u2014a review of its pharmacology, therapeutic use and new developments. Anaesthesia 59(4):364\u2013373","journal-title":"Anaesthesia"},{"issue":"9","key":"936_CR46","first-page":"864","volume":"11","author":"V Kumar","year":"2019","unstructured":"Kumar V (2019) Endoplasmic reticulum-mitochondrial cross-talk in neurodegenerative and eye diseases. Neurology (ECronicon) 11(9):864\u2013873","journal-title":"Neurology (ECronicon)"},{"key":"936_CR47","first-page":"1687","volume":"11 Pt B","author":"A Kushnir","year":"1865","unstructured":"Kushnir A, Wajsberg B (1865) Marks AR (2018) Ryanodine receptor dysfunction in human disorders. Biochim Biophys Acta Mol Cell Res 11 Pt B:1687\u20131697","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"2","key":"936_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ceca.2016.04.005","volume":"60","author":"RM La Rovere","year":"2016","unstructured":"La Rovere RM, Roest G, Bultynck G, Parys JB (2016) Intracellular Ca(2+) signaling and Ca(2+) microdomains in the control of cell survival, apoptosis and autophagy. Cell Calcium 60(2):74\u201387","journal-title":"Cell Calcium"},{"issue":"5","key":"936_CR49","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-017-1733-7","volume":"134","author":"A Lacampagne","year":"2017","unstructured":"Lacampagne A, Liu X, Reiken S, Bussiere R, Meli AC, Lauritzen I, Teich AF, Zalk R, Saint N, Arancio O et al (2017) Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits. Acta Neuropathol 134(5):749\u2013767","journal-title":"Acta Neuropathol"},{"issue":"Pt 2","key":"936_CR50","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1042\/bj2880553","volume":"288","author":"FA Lai","year":"1992","unstructured":"Lai FA, Dent M, Wickenden C, Xu L, Kumari G, Misra M, Lee HB, Sar M, Meissner G (1992) Expression of a cardiac Ca(2+)-release channel isoform in mammalian brain. Biochem J 288(Pt 2):553\u2013564","journal-title":"Biochem J"},{"issue":"5","key":"936_CR51","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/mds.27360","volume":"33","author":"AE Lang","year":"2018","unstructured":"Lang AE, Espay AJ (2018) Disease modification in parkinson's disease: current approaches, challenges, and future considerations. Mov Disord 33(5):660\u2013677","journal-title":"Mov Disord"},{"key":"936_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-94-007-2888-2_9","volume":"740","author":"JT Lanner","year":"2012","unstructured":"Lanner JT (2012) Ryanodine receptor physiology and its role in disease. Adv Exp Med Biol 740:217\u2013234","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"936_CR53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/17482968.2011.641569","volume":"13","author":"J Lautenschlaeger","year":"2012","unstructured":"Lautenschlaeger J, Prell T, Grosskreutz J (2012) Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13(2):166\u2013177","journal-title":"Amyotroph Lateral Scler"},{"issue":"13","key":"936_CR54","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1021\/acs.jmedchem.6b00297","volume":"59","author":"G Le Douaron","year":"2016","unstructured":"Le Douaron G, Ferrie L, Sepulveda-Diaz JE, Amar M, Harfouche A, Seon-Meniel B, Raisman-Vozari R, Michel PP, Figadere B (2016) New 6-aminoquinoxaline derivatives with neuroprotective effect on dopaminergic neurons in cellular and animal parkinson disease models. J Med Chem 59(13):6169\u20136186","journal-title":"J Med Chem"},{"key":"936_CR56","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fncel.2015.00225","volume":"9","author":"SS Leal","year":"2015","unstructured":"Leal SS, Gomes CM (2015) Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability. Front Cell Neurosci 9:225","journal-title":"Front Cell Neurosci"},{"issue":"35","key":"936_CR55","doi-asserted-by":"publisher","first-page":"25219","DOI":"10.1074\/jbc.M113.470740","volume":"288","author":"SS Leal","year":"2013","unstructured":"Leal SS, Cardoso I, Valentine JS, Gomes CM (2013) Calcium ions promote superoxide dismutase 1 (SOD1) aggregation into non-fibrillar amyloid: a link to toxic effects of calcium overload in amyotrophic lateral sclerosis (ALS)? J Biol Chem 288(35):25219\u201325228","journal-title":"J Biol Chem"},{"issue":"1","key":"936_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WAD.0000000000000076","volume":"29","author":"L Liang","year":"2015","unstructured":"Liang L, Wei H (2015) Dantrolene, a treatment for Alzheimer disease? Alzheimer Dis Assoc Disord 29(1):1\u20135","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"29","key":"936_CR59","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","volume":"29","author":"J Liu","year":"2009","unstructured":"Liu J, Tang TS, Tu H, Nelson O, Herndon E, Huynh DP, Pulst SM, Bezprozvanny I (2009) Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J Neurosci 29(29):9148\u20139162","journal-title":"J Neurosci"},{"issue":"3","key":"936_CR58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4161\/chan.27471","volume":"8","author":"J Liu","year":"2014","unstructured":"Liu J, Supnet C, Sun S, Zhang H, Good L, Popugaeva E, Bezprozvanny I (2014) The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease. Channels (Austin) 8(3):230\u2013242","journal-title":"Channels (Austin)"},{"issue":"10","key":"936_CR60","doi-asserted-by":"publisher","first-page":"e46999","DOI":"10.1371\/journal.pone.0046999","volume":"7","author":"VF Low","year":"2012","unstructured":"Low VF, Fiorini Z, Fisher L, Jasoni CL (2012) Netrin-1 stimulates developing GnRH neurons to extend neurites to the median eminence in a calcium- dependent manner. PLoS ONE 7(10):e46999","journal-title":"PLoS ONE"},{"issue":"22","key":"936_CR61","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1073\/pnas.86.22.8683","volume":"86","author":"AR Marks","year":"1989","unstructured":"Marks AR, Tempst P, Hwang KS, Taubman MB, Inui M, Chadwick C, Fleischer S, Nadal-Ginard B (1989) Molecular cloning and characterization of the ryanodine receptor\/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc Natl AcadSci U S A 86(22):8683\u20138687","journal-title":"Proc Natl AcadSci U S A"},{"issue":"1","key":"936_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0306-4522(97)00612-X","volume":"85","author":"C Martin","year":"1998","unstructured":"Martin C, Chapman KE, Seckl JR, Ashley RH (1998) Partial cloning and differential expression of ryanodine receptor\/calcium-release channel genes in human tissues including the hippocampus and cerebellum. Neuroscience 85(1):205\u2013216","journal-title":"Neuroscience"},{"key":"936_CR63","doi-asserted-by":"publisher","first-page":"104343","DOI":"10.1016\/j.phrs.2019.104343","volume":"147","author":"A Masi","year":"2019","unstructured":"Masi A, Narducci R, Mannaioni G (2019) Harnessing ionic mechanisms to achieve disease modification in neurodegenerative disorders. Pharmacol Res 147:104343","journal-title":"Pharmacol Res"},{"issue":"31","key":"936_CR64","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.2174\/0929867321666140601161148","volume":"21","author":"P Menon","year":"2014","unstructured":"Menon P, Kiernan MC, Vucic S (2014) Biomarkers and future targets for development in amyotrophic lateral sclerosis. Curr Med Chem 21(31):3535\u20133550","journal-title":"Curr Med Chem"},{"issue":"2","key":"936_CR65","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1471-4159.2006.04424.x","volume":"101","author":"PP Michel","year":"2007","unstructured":"Michel PP, Alvarez-Fischer D, Guerreiro S, Hild A, Hartmann A, Hirsch EC (2007) Role of activity-dependent mechanisms in the control of dopaminergic neuron survival. J Neurochem 101(2):289\u2013297","journal-title":"J Neurochem"},{"issue":"4","key":"936_CR66","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90(4):675\u2013691","journal-title":"Neuron"},{"key":"936_CR67","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fcell.2019.00172","volume":"7","author":"O Moltedo","year":"2019","unstructured":"Moltedo O, Remondelli P, Amodio G (2019) The mitochondria-endoplasmic reticulum contacts and their critical role in aging and age-associated diseases. Front Cell Dev Biol 7:172","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"936_CR68","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12028-008-9133-4","volume":"10","author":"S Muehlschlegel","year":"2009","unstructured":"Muehlschlegel S, Sims JR (2009) Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit Care 10(1):103\u2013115","journal-title":"Neurocrit Care"},{"issue":"1\u20132","key":"936_CR69","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0014-5793(90)80399-4","volume":"271","author":"J Nakai","year":"1990","unstructured":"Nakai J, Imagawa T, Hakamat Y, Shigekawa M, Takeshima H, Numa S (1990) Primary structure and functional expression from cDNA of the cardiac ryanodine receptor\/calcium release channel. FEBS Lett 271(1\u20132):169\u2013177","journal-title":"FEBS Lett"},{"issue":"1","key":"936_CR70","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0014-5793(97)01275-1","volume":"417","author":"Y Nakashima","year":"1997","unstructured":"Nakashima Y, Nishimura S, Maeda A, Barsoumian EL, Hakamata Y, Nakai J, Allen PD, Imoto K, Kita T (1997) Molecular cloning and characterization of a human brain ryanodine receptor. FEBS Lett 417(1):157\u2013162","journal-title":"FEBS Lett"},{"issue":"1","key":"936_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541(1):163\u2013166","journal-title":"Brain Res"},{"issue":"4","key":"936_CR72","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/dneu.22139","volume":"74","author":"R Ohashi","year":"2014","unstructured":"Ohashi R, Sakata S, Naito A, Hirashima N, Tanaka M (2014) Dendritic differentiation of cerebellar Purkinje cells is promoted by ryanodine receptors expressed by Purkinje and granule cells. Dev Neurobiol 74(4):467\u2013480","journal-title":"Dev Neurobiol"},{"issue":"5","key":"936_CR73","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1074\/jbc.M005070200","volume":"276","author":"N Ohkubo","year":"2001","unstructured":"Ohkubo N, Mitsuda N, Tamatani M, Yamaguchi A, Lee YD, Ogihara T, Vitek MP, Tohyama M (2001) Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway. J Biol Chem 276(5):3046\u20133053","journal-title":"J Biol Chem"},{"issue":"34","key":"936_CR74","doi-asserted-by":"publisher","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","volume":"32","author":"B Oules","year":"2012","unstructured":"Oules B, Del PD, Greco B, Zhang X, Lauritzen I, Sevalle J, Moreno S, Paterlini-Brechot P, Trebak M, Checler F et al (2012) Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci 32(34):11820\u201311834","journal-title":"J Neurosci"},{"issue":"1","key":"936_CR75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s13311-016-0492-9","volume":"14","author":"SB Park","year":"2017","unstructured":"Park SB, Kiernan MC, Vucic S (2017) Axonal excitability in amyotrophic lateral sclerosis: axonal excitability in ALS. Neurotherapeutics 14(1):78\u201390","journal-title":"Neurotherapeutics"},{"issue":"4","key":"936_CR76","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.bbrc.2016.08.089","volume":"483","author":"R Patai","year":"2017","unstructured":"Patai R, Nogradi B, Engelhardt JI, Siklos L (2017) Calcium in the pathomechanism of amyotrophic lateral sclerosis - Taking center stage? Biochem Biophys Res Commun 483(4):1031\u20131039","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"936_CR77","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","volume":"516","author":"J Peng","year":"2012","unstructured":"Peng J, Liang G, Inan S, Wu Z, Joseph DJ, MengQ PY, Eckenhoff MF, Wei H (2012) Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice. Neurosci Lett 516(2):274\u2013279","journal-title":"Neurosci Lett"},{"issue":"1","key":"936_CR78","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/hbm.24790","volume":"41","author":"L Pini","year":"2020","unstructured":"Pini L, Jacquemot C, Cagnin A, Meneghello F, Semenza C, Mantini D, Vallesi A (2020) Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: a systematic review. Hum Brain Mapp 41(1):256\u2013269","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"936_CR79","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbrc.2016.09.053","volume":"483","author":"E Popugaeva","year":"2017","unstructured":"Popugaeva E, Pchitskaya E, Bezprozvanny I (2017) Dysregulation of neuronal calcium homeostasis in Alzheimer's disease\u2014a therapeutic opportunity? Biochem Biophys Res Commun 483(4):998\u20131004","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"936_CR80","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.tibs.2016.09.001","volume":"41","author":"A Raffaello","year":"2016","unstructured":"Raffaello A, Mammucari C, Gherardi G, Rizzuto R (2016) Calcium at the center of cell signaling: interplay between endoplasmic reticulum, mitochondria, and lysosomes. Trends Biochem Sci 41(12):1035\u20131049","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"936_CR81","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbrc.2016.07.058","volume":"483","author":"LA Raymond","year":"2017","unstructured":"Raymond LA (2017) Striatal synaptic dysfunction and altered calcium regulation in Huntington disease. Biochem Biophys Res Commun 483(4):1051\u20131062","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"936_CR82","doi-asserted-by":"publisher","first-page":"R425","DOI":"10.1016\/S0960-9822(03)00358-0","volume":"13","author":"HL Roderick","year":"2003","unstructured":"Roderick HL, Berridge MJ, Bootman MD (2003) Calcium-induced calcium release. Curr Biol 13(11):R425","journal-title":"Curr Biol"},{"issue":"2","key":"936_CR83","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1471-4159.1995.65020643.x","volume":"65","author":"JD Rothstein","year":"1995","unstructured":"Rothstein JD, Kuncl RW (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 65(2):643\u2013651","journal-title":"J Neurochem"},{"issue":"1","key":"936_CR84","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.biocel.2007.06.023","volume":"40","author":"V Rybalchenko","year":"2008","unstructured":"Rybalchenko V, Hwang SY, Rybalchenko N, Koulen P (2008) The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. Int J Biochem Cell Biol 40(1):84\u201397","journal-title":"Int J Biochem Cell Biol"},{"key":"936_CR85","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-981-10-7757-9_11","volume":"87","author":"G Santulli","year":"2018","unstructured":"Santulli G, Lewis D, des Georges A, Marks AR, Frank J (2018) Ryanodine receptor structure and function in health and disease. Subcell Biochem 87:329\u2013352","journal-title":"Subcell Biochem"},{"issue":"9","key":"936_CR86","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2174\/1871527317666180619162649","volume":"18","author":"Y Shi","year":"2019","unstructured":"Shi Y, Wang Y, Wei H (2019a) Dantrolene: from malignant hyperthermia to Alzheimer's disease. CNS Neurol Disord Drug Targets 18(9):668\u2013676","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"7","key":"936_CR87","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jalz.2019.06.2476","volume":"15","author":"Y Shi","year":"2019","unstructured":"Shi Y, Zhang L, Gao X, Zhang J, Ben-Abou M, Meng Q, Hepner A, Eckenhoff MF, Wei H (2019b) Intranasal dantrolene as a disease-modifying drug in Alzheimer 5XFAD mice. Alzheimers Dement 15(7):597","journal-title":"Alzheimers Dement"},{"key":"936_CR88","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200227","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zhang L, Gao X, Zhang J, Ben-Abou M, Liang G, Meng Q, Hepner A, Eckenhoff MF, Wei H (2020) Intranasal dantrolene as a disease-modifying drug in Alzheimer 5XFAD mice. J Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-200227","journal-title":"J Alzheimers Dis"},{"key":"936_CR89","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fnins.2018.00510","volume":"12","author":"R Sirabella","year":"2018","unstructured":"Sirabella R, Valsecchi V, Anzilotti S, Cuomo O, Vinciguerra A, Cepparulo P, Brancaccio P, Guida N, Blondeau N, Canzoniero L et al (2018) Ionic homeostasis maintenance in ALS: focus on new therapeutic targets. Front Neurosci 12:510","journal-title":"Front Neurosci"},{"key":"936_CR90","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuroscience.2012.06.050","volume":"220","author":"KA Staats","year":"2012","unstructured":"Staats KA, Van Rillaer M, Scheveneels W, Verbesselt R, Van Damme P, Robberecht W, Van Den Bosch L (2012) Dantrolene is neuroprotective in vitro, but does not affect survival in SOD1(G(9)(3)A) mice. Neuroscience 220:26\u201331","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"936_CR91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0006-8993(92)91235-7","volume":"585","author":"MB Stein","year":"1992","unstructured":"Stein MB, Padua RA, Nagy JI, Geiger JD (1992) High affinity [3H] ryanodine binding sites in postmortem human brain: regional distribution and effects of calcium, magnesium and caffeine. Brain Res 585(1\u20132):349\u2013354","journal-title":"Brain Res"},{"issue":"19","key":"936_CR92","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1523\/JNEUROSCI.0739-06.2006","volume":"26","author":"GE Stutzmann","year":"2006","unstructured":"Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I (2006) Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J Neurosci 26(19):5180\u20135189","journal-title":"J Neurosci"},{"issue":"8","key":"936_CR93","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tins.2014.05.008","volume":"37","author":"DJ Sutherland","year":"2014","unstructured":"Sutherland DJ, Pujic Z, Goodhill GJ (2014) Calcium signaling in axon guidance. Trends Neurosci 37(8):424\u2013432","journal-title":"Trends Neurosci"},{"issue":"1\u20132","key":"936_CR94","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbrc.2012.10.107","volume":"429","author":"M Suzuki","year":"2012","unstructured":"Suzuki M, Nagai Y, Wada K, Koike T (2012) Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin. Biochem Biophys Res Commun 429(1\u20132):18\u201323","journal-title":"Biochem Biophys Res Commun"},{"key":"936_CR95","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fncel.2014.00147","volume":"8","author":"V Tadic","year":"2014","unstructured":"Tadic V, Prell T, Lautenschlaeger J, Grosskreutz J (2014) The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Front Cell Neurosci 8:147","journal-title":"Front Cell Neurosci"},{"issue":"28","key":"936_CR96","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1523\/JNEUROSCI.0871-05.2005","volume":"25","author":"F Tang","year":"2005","unstructured":"Tang F, Kalil K (2005) Netrin-1 induces axon branching in developing cortical neurons by frequency-dependent calcium signaling pathways. J Neurosci 25(28):6702\u20136715","journal-title":"J Neurosci"},{"issue":"7","key":"936_CR97","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1073\/pnas.0409402102","volume":"102","author":"TS Tang","year":"2005","unstructured":"Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, Kristal BS, Hayden MR, Bezprozvanny I (2005) Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc Natl Acad Sci U S A 102(7):2602\u20132607","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"936_CR98","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/cells8101216","volume":"8","author":"V Tedeschi","year":"2019","unstructured":"Tedeschi V, Petrozziello T, Secondo A (2019) Calcium dyshomeostasis and lysosomal Ca(2+) dysfunction in amyotrophic lateral sclerosis. Cells 8(10):1216","journal-title":"Cells"},{"issue":"3","key":"936_CR99","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1474-9726.2007.00295.x","volume":"6","author":"O Thibault","year":"2007","unstructured":"Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6(3):307\u2013317","journal-title":"Aging Cell"},{"key":"936_CR100","first-page":"1745","volume":"11 Pt B","author":"BC Tong","year":"1865","unstructured":"Tong BC, Wu AJ, Li M (1865) Cheung KH (2018) Calcium signaling in Alzheimer's disease & therapies. Biochim Biophys Acta Mol Cell Res 11 Pt B:1745\u20131760","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"3","key":"936_CR101","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nbd.2011.01.016","volume":"42","author":"ML Tradewell","year":"2011","unstructured":"Tradewell ML, Cooper LA, Minotti S, Durham HD (2011) Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention. Neurobiol Dis 42(3):265\u2013275","journal-title":"Neurobiol Dis"},{"key":"936_CR102","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fncel.2018.00089","volume":"12","author":"T Vervliet","year":"2018","unstructured":"Vervliet T (2018) Ryanodine receptors in autophagy: implications for neurodegenerative diseases? Front Cell Neurosci 12:89","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"936_CR105","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4172\/2161-0460.1000374","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang Y, Shi Y, Wei H (2017) Calcium dysregulation in Alzheimer's disease: a target for new drug development. J Alzheimers Dis Parkinsonism 7(5):374","journal-title":"J Alzheimers Dis Parkinsonism"},{"issue":"7","key":"936_CR103","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jalz.2019.06.3108","volume":"15","author":"J Wang","year":"2019","unstructured":"Wang J, Shi Y, Yu S, Wang Y, Meng Q, Liang G, EckenhoffMF WH (2019) Intranasal administration of dantrolene increased its concentrations and durations in the brain. Alzheimers Dement 15(7):957","journal-title":"Alzheimers Dement"},{"issue":"3","key":"936_CR104","first-page":"e229156","volume":"15","author":"J Wang","year":"2020","unstructured":"Wang J, Shi Y, Yu S, Wang Y, Meng Q, Liang G, Eckenhoff MF, Wei H (2020) Intranasal administration of dantrolene increased brain concentration and duration. PLoS ONE 15(3):e229156","journal-title":"PLoS ONE"},{"issue":"6","key":"936_CR106","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1046\/j.1471-4159.1996.67062390.x","volume":"67","author":"H Wei","year":"1996","unstructured":"Wei H, Perry DC (1996) Dantrolene is cytoprotective in two models of neuronal cell death. J Neurochem 67(6):2390\u20132398","journal-title":"J Neurochem"},{"issue":"1","key":"936_CR107","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/156720509787313934","volume":"6","author":"H Wei","year":"2009","unstructured":"Wei H, Xie Z (2009) Anesthesia, calcium homeostasis and Alzheimer's disease. Curr Alzheimer Res 6(1):30\u201335","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"936_CR108","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/WAD.0000000000000075","volume":"29","author":"Z Wu","year":"2015","unstructured":"Wu Z, Yang B, Liu C, Liang G, Eckenhoff MF, Liu W, Pickup S, Meng Q, Tian Y, Li S et al (2015) Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice. Alzheimer Dis Assoc Disord 29(3):184\u2013191","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"936_CR109","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/JAD-122419","volume":"35","author":"C Xiao","year":"2013","unstructured":"Xiao C, Davis FJ, Chauhan BC, Viola KL, Lacor PN, Velasco PT, Klein WL, Chauhan NB (2013) Brain transit and ameliorative effects of intranasally delivered anti-amyloid-beta oligomer antibody in 5XFAD mice. J Alzheimers Dis 35(4):777\u2013788","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"936_CR110","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.neuroscience.2010.02.020","volume":"167","author":"K Xu","year":"2010","unstructured":"Xu K, Xu YH, Chen JF, Schwarzschild MA (2010) Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience 167(2):475\u2013481","journal-title":"Neuroscience"},{"issue":"1","key":"936_CR111","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JAD-180858","volume":"67","author":"M Yang","year":"2019","unstructured":"Yang M, Wang Y, Liang G, Xu Z, Chu CT, Wei H (2019) Alzheimer's disease presenilin-1 mutation sensitizes neurons to impaired autophagy flux and propofol neurotoxicity: role of calcium dysregulation. J Alzheimers Dis 67(1):137\u2013147","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"936_CR114","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0304-3940(93)90623-S","volume":"158","author":"L Zhang","year":"1993","unstructured":"Zhang L, Andou Y, Masuda S, Mitani A, Kataoka K (1993) Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci Lett 158(1):105\u2013108","journal-title":"Neurosci Lett"},{"issue":"25","key":"936_CR113","doi-asserted-by":"publisher","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","volume":"30","author":"H Zhang","year":"2010","unstructured":"Zhang H, Sun S, Herreman A, De Strooper B, Bezprozvanny I (2010) Role of presenilins in neuronal calcium homeostasis. J Neurosci 30(25):8566\u20138580","journal-title":"J Neurosci"},{"issue":"2","key":"936_CR112","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-142427","volume":"45","author":"H Zhang","year":"2015","unstructured":"Zhang H, Liu J, Sun S, PchitskayaE PE, Bezprozvanny I (2015) Calcium signaling, excitability, and synaptic plasticity defects in a mouse model of Alzheimer's disease. J Alzheimers Dis 45(2):561\u2013580","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"936_CR115","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1089\/ars.2010.3359","volume":"14","author":"G Zundorf","year":"2011","unstructured":"Zundorf G, Reiser G (2011) Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal 14(7):1275\u20131288","journal-title":"Antioxid Redox Signal"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-020-00936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-020-00936-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-020-00936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T16:27:10Z","timestamp":1633796830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-020-00936-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":115,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1007\/s10571-020-00936-w","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"9 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Huafeng Wei was once a member of the Advisory Board of Eagle Pharmaceutical Company for a one-day meeting in 2017 and the contract expired now. Eagle Pharmaceutical Company produces and sells Ryanodex, a new formula of dantrolene. Dr. Huafeng Wei is one of the inventors for a US patent application using intranasal dantrolene to treat Alzheimer\u2019s disease in 2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}